These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17203795)

  • 1. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular manifestations in human immunodeficiency virus-infected patients.
    Khunnawat C; Mukerji S; Havlichek D; Touma R; Abela GS
    Am J Cardiol; 2008 Sep; 102(5):635-42. PubMed ID: 18721528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and the cardiovascular system.
    Barbaro G; Klatt EC
    AIDS Rev; 2002; 4(2):93-103. PubMed ID: 12152522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of the involvement of the cardiovascular system in HIV infection.
    Barbarinia G; Barbaro G
    AIDS; 2003 Apr; 17 Suppl 1():S46-50. PubMed ID: 12870530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical cardiac manifestations of HIV infection: a review of current literature.
    Chu WW; Sosman JM; Stein JH
    WMJ; 2002; 101(7):40-5, 39. PubMed ID: 12426919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in patients infected with the human immunodeficiency virus.
    Velasquez EM; Glancy DL
    J La State Med Soc; 2003; 155(6):314-24. PubMed ID: 14750751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV-associated cardiomyopathy].
    Neumann T; Kondratieva J; Breuckmann F; Erbel R;
    Herz; 2005 Sep; 30(6):545-9. PubMed ID: 16170687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated cardiomyopathy etiopathogenesis and clinical aspects.
    Barbaro G
    Herz; 2005 Sep; 30(6):486-92. PubMed ID: 16170679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk and risk management in HIV-infected patients.
    Adeyemi O
    Top HIV Med; 2007; 15(5):159-62. PubMed ID: 18073451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing HIV. Part 5: Treating secondary outcomes. 5.9 HIV-related cardiovascular disease.
    Feneley MP
    Med J Aust; 1996 Apr; 164(8):482. PubMed ID: 8614340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
    Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
    Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related cardiovascular disease and drug interactions.
    Nanavati KA; Fisher SD; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2004; 4(5):315-24. PubMed ID: 15449973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.
    Wanke CA; Falutz JM; Shevitz A; Phair JP; Kotler DP
    Clin Infect Dis; 2002 Jan; 34(2):248-59. PubMed ID: 11740715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?
    Torre D; Pugliese A
    AIDS Rev; 2010; 12(1):31-9. PubMed ID: 20216908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
    Bevilacqua M; Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.